Economic evaluation of end stage renal disease patients undergoing hemodialysis

Journal of Pharmacy and Bioallied Sciences

Volumn 4, Issue 2, 2012, Pages 107-111

  Suja, A ^a,b   Anju, R ^a   Anju, V ^a   Neethu, J ^a   Peeyush, P ^a   Saraswathy, R ^c  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^b KARPAGAM UNIVERSITY   (India)

^c AL SHIFA COLLEGE OF PHARMACY   (India)

Author keywords

Cost analysis; end stage renal disease; hemodialysis; pharmacoeconomics

Indexed keywords

ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DYSPNEA; ECONOMIC EVALUATION; FEMALE; HEALTH CARE; HEALTH CARE COST; HEMODIALYSIS; HUMAN; HYPOTENSION; INDIA; INFECTION; KIDNEY FAILURE; MALE; MUSCLE CRAMP; NAUSEA; OBSERVATIONAL STUDY; PATIENT SATISFACTION; PATIENT SELECTION; PHARMACOECONOMICS; PRIORITY JOURNAL; PRIVATE HOSPITAL; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; REIMBURSEMENT; RENAL REPLACEMENT THERAPY; SOCIAL STATUS; TERTIARY HEALTH CARE; VOMITING;

EID: 84859782544     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.94810     Document Type: Article

References (37)

1. Juan GP, Luke V, Sally CS, Sarah W. Hemodialysis for ESRD: A cost effectiveness analysis of treatment options. Int J Tech Ass Healthcare 2005;21:32-9.
2. Revikumar KG, Miglani BD. Pharmacoeconomics and Quality of Life. A Text book of Pharmacy Practice. 1st ed. Nasik, India: Career Publication; 2009. p. 443-95.
3. Pashos CL, Klein EG, Wanke LA. ISPOR Lexicon. 1st ed. Princeton, NJ: International Society for Pharmacoeconomics and Outcome Research; p. 1998.
4. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Ann Intern Med 2003;139:137-47.
5. Dash SC, Agarwal SK. Incidence of chronic kidney disease in India. Nephrol Dial Transplant 2006;21:232-3.
6. US Renal Data System. USRDS 2007 annual data report: Atlas of end stage renal disease in the United States, National Institute of Health. Minneapolis: USRDS; 2007.
7. Hallan SI, Vikse BE. Relationship between chronic kidney disease prevalence and end stage renal disease risk. Curr Opin Nephrol Hypertens 2008;17:286-91.
8. Daphne K, Panagiotis NZ, Nikolaos M, Lycurgus LL. Economic evaluation of hemodialysis: Implications for technology assessment in Greece. Int J Tech Ass Healthcare 2005;21:40-6.
9. Prodjosudjadi W, Suhardjono A. End stage renal disease in Indonesia: Treatment development. Ethn Dis 2009;19(1 Suppl 1): S1-33-6.
10. Ballal HS. The burden of chronic kidney disease in a developing country, India. Ouest 2007;9:12-9.
11. Agarwal SK, Dash SC, Irshad M, Raju S, Singh R, Pandey RM. Prevalence of chronic renal failure in adults in Delhi, India. Nephrol Dial Transplant 2005;20:1638-42.
12. Mani MK. Prevention of chronic renal failure at the community level. Kidney Int Suppl 2003;(83): S86-9.
13. Kher V. End stage renal disease in developing countries. Kidney Int 2002;62:350-62.
14. Nick K, Dimitris N, John M. A socioeconomic comparison of hemodialysis and peritonial dialysis in Greece. Int J Healthc Tech Manage 2005;13:296-306.
15. Crealey GE, Sturgess IK, McElnay JC, Hughes CM. Pharmaceutical care programmes for the Elderly: Economic issues. Pharmaeconomics 2003;21:455-65.
16. Sakhuja V, Sud K. End stage renal disease in India and Pakistan: Burden of disease and management issues. Kidney Int 2003;63:S115-8.
17. Khanna U. The economics of dialysis in India. Ind J of Nephrology 2009;19:1-4.
18. Elsharif ME, Elsharif EG, Gadour WH. Cost of hemodialysis and kidney transplantation in Sudan- A single center experience. Iran J Kidney Dis 2010;4:282-4.
19. Adomakoh SA, Adi CN, Fraser HS, Nicholson GD. Dialysis in Barbados: The cost of hemodialysis provision at the queen elizabeth hospital. Rev Panam Salud Publica 2004;16:350-5.
20. Salonen T, Reina T, Oksa H, Sintonen H, Pasternack A. Cost analysis of renal replacement therapies in Finland. Am J Kidney Dis 2005;42:1228-38.
21. Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, et al. Cost analysis of ongoing care of patient with ESRD: The impact of dialysis modality and dialysis. Am J Kidney Dis 2002;40:611-22.
22. Abraham G, Jayaseelan T, Matthew M, Padma P, Saravanan AK, Lesley N, et al. Resource settings have a major influence on the outcome of maintenance hemodialysis patients in South India. Hemodial Int 2010;14:211-7.
23. Manandhar DN, Chhetri PK, Tiwari R, Lamichhane S. Evaluation of dialysis adequacy in patients under hemodialysis and effectiveness of dialysere reuses. Nepal Med Coll J 2009;11:107-10.
24. Modi GK, Jha V. The incidence of ESRD in India: A population based study. Kidney Int 2006;70: 2131-3.
25. Hooi LS. Incidence of end stage renal failure in Johore, Malaysia. Med J Malaysia 1994;49:360-8.
26. Croxson BE, Ashton T. A cost effectiveness analysis of the treatment of ESRF. NZ Med J 1990;103:171-4.
27. Zelmer JR. The economic burden of end stage renal disease in Canada. Kidney Int 2007;72:1122-9.
28. Tediosi F, Bertolini G, Parazzini F, Mecca G, Garattini L. Cost analysis of dialysis modalities in Italy. Health Serv Manage Res 2001;14:9-17.
29. Ardine GW, Paul GR. Economic evaluation of ESRD treatment. Health Policy 1998;44:215-32.
30. Gardner TI, Dardis R. Cost effectiveness analysis of ESRD treatments. Med Care 1987;25:25-34.
31. RAND, KDQOL-SFTM User's manual, 1993.
32. DiMatteo MR, Hays R. The significance of Patient's Perceptions of Physician conduct: A study of patient satisfaction in a family practice center. J Community Health 1980;6:18-34.
33. Kumar N, Shekhar C, Kumar P, Kundu AS. Kuppuswamy's socioeconomic status scale-updating for 2007. Indian J Pediatr 2007;74:1131-2.
34. Rao M, Juneja R, Shirley Rd, Jacob CK. Hemodialysis for end stage renal disease in Southern India. A perspective from a tertiary care center. Nephrol Dial Transplant 1998;13:2494-500.
35. Mittal S, Kher V, Gulati S, Agarwal LK, Arora P. Chronic renal failure in India. Ren Fail 1997;19:763-70.
36. Jha V, Chugh KS. Dialysis in developing countries: Priorities and obstacles. Nephrology 1996;2:65-72.
37. Mani MK. The management of end stage renal disease in India. Artif Organs 1998;22:182-6.